• New role will boost strategy for scalable solutions
    Peter Crossley

Company News

New role will boost strategy for scalable solutions

Feb 15 2024

TTP Company Cellular Origins has appointed Peter Crossley as Chief Operating Officer (COO), to bolster Cellular Origins’ mission to develop scalable automation solutions for cell therapy manufacture. Bringing 27 years’ experience in novel technology and product development to this key role, he will be responsible for driving team growth and overseeing people development at the company.

Having worked as a Consultant at TTP for the past 17 years, he was most recently interim CTO at Depixus. With a BEng in Aerospace Engineering from the University of Bristol, Peter began his career in gas turbine development at Rolls-Royce, before moving to R&D and technical management in consumer products at Dyson and Fisher & Paykel.

“Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life changing treatments to all who need them.”

Dr Edwin Stone, CEO at Cellular Origins, added: “I am delighted to welcome Peter. His proven cross-sector experience, leadership skills and ability to turn ground-breaking innovation into commercial reality, will accelerate our mission to develop scalable automation solutions for cell therapies.”

More information online


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

ASMS Conference

Jun 02 2024 Anaheim, CA, USA

ACHEMA 2024

Jun 10 2024 Frankfurt, Germany

Lab & Test Asia

Jun 12 2024 Bangkok, Thailand

Chemspec Europe 2024

Jun 19 2024 Dusseldorf, Germany

Forensics Europe Expo

Jun 19 2024 London, UK

View all events